This HTML5 document contains 200 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://dx.doi.org/10.1038/
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37835695
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в лютому 2011 wetenschappelijk artikel articolo scientifico article scientifique vedecký článok wissenschaftlicher Artikel vetenskaplig artikel article científic artigo científico artículu científicu espublizáu en 2011 مقالة علمية نشرت في 04 فبراير 2011 bilimsel makale videnskabelig artikel scientific article published on 04 February 2011 научни чланак vědecký článek
p:P577
wds:Q37835695-DF7CE369-E8E9-4D96-B189-F11ECCB35401
wdt:P577
2011-02-04T00:00:00Z
p:P2888
wds:Q37835695-BF79BA0B-CD65-45CC-91E1-E78B5A3F9CBC
wdt:P2888
n9:leu.2011.3
p:P2860
wds:Q37835695-E1F56196-A00F-45FD-B77B-84AAE76AE2C6 wds:Q37835695-E524E6F5-3755-47D1-9D96-7FACF2607FBF wds:Q37835695-E91FFFD9-3FAD-4EC2-83A9-86D3C3E53707 wds:Q37835695-E95D227F-5C0B-4AE3-8F55-85FF5739AEBE wds:Q37835695-DFA8A8F0-B42D-40C7-9F95-82ED29111D65 wds:Q37835695-FC74D8AD-5785-4325-9747-54A0BED42705 wds:Q37835695-F8038BD5-88E4-4809-9EB2-A6D4612FC5F6 wds:Q37835695-F9AC51A9-B9C3-4E8A-90DB-A68034B983B7 wds:Q37835695-FABD396E-D847-4F05-ADE8-0FDFF2473049 wds:Q37835695-40E2A2CE-10A8-4006-933E-7C947DE2865A wds:Q37835695-2C5B933D-316F-4773-95E2-6BA64505FCD2 wds:Q37835695-2CBED233-D7C9-420A-9998-6F738F483F7D wds:Q37835695-4C468351-BF16-4523-8B89-46CBFAFEC7C3 wds:Q37835695-57551855-905E-4F73-B158-C8771741D8C2 wds:Q37835695-61D060E3-E10F-437B-BCA4-81B2F2CE957F wds:Q37835695-434C0E8A-7B9E-49FB-BC4F-04398D78512C wds:Q37835695-48B56DC6-FE4E-407D-8377-FFA139D9B670 wds:Q37835695-1664F275-2F32-4B06-BF12-04ABA1943A2F wds:Q37835695-1BEC942C-C45F-4D18-A5A4-58A2EA4D42D9 wds:Q37835695-14435C3F-D25F-4A98-BB11-8F3EC2B64F04 wds:Q37835695-1563389E-D5CA-48E3-AD8F-8BA3662C5F43 wds:Q37835695-1599F043-33BD-4D4F-B2DC-432F658309E0 wds:Q37835695-23661CE9-EB55-4195-A4BE-F8280C5C2028 wds:Q37835695-25713486-B5B9-4FD7-91D9-186F578688FC wds:Q37835695-28596ED0-A8AF-404D-B6FB-FA6DD6B03BAE wds:Q37835695-2970ABD7-9D70-40FC-B34C-7A56DEF69B2C wds:Q37835695-1C0FC25D-6030-4996-A203-703DABF3174B wds:Q37835695-1FC48E52-1071-41B9-AD90-51B4394E966B wds:Q37835695-22B68686-378C-4EBD-98E9-BBC859EE0A73 wds:Q37835695-C110F270-B344-47FB-98EA-79F0B77B6F84 wds:Q37835695-C1B78A85-4DD7-4E4B-BD84-D6F5AB67E961 wds:Q37835695-A3E04D3E-62B4-4D21-947B-BF9F3206BFE6 wds:Q37835695-A748C6FC-BCB8-4B06-A1FB-6A3C1764CC8A wds:Q37835695-D69AD15B-05FD-4D2E-8F52-6EB752964FAC wds:Q37835695-DA1D0554-38D4-4DB8-B872-0653235011FC wds:Q37835695-CB67DB41-6B1E-4C29-9742-B377B20D3C98 wds:Q37835695-CC4735E9-1ACE-4879-ACBD-0EFF5D93FE5D wds:Q37835695-78D26A12-6D43-41F5-BFF7-63F2C5421300 wds:Q37835695-8570DC94-37E2-4415-94EB-6B5DE21229CE wds:Q37835695-693EDAB1-92EE-49F6-8A11-6D344CDC50DF wds:Q37835695-6E4DAEB0-C7AD-4593-8592-D5BAB5E193F6 wds:Q37835695-78B41ABB-E96D-4888-AAC2-7C56A7161600 wds:Q37835695-9697DF53-4EE8-44AA-A320-A91BB7BEE064 wds:Q37835695-9A46FD00-D3A3-4A43-ABE4-CC4489FA7B3C wds:Q37835695-8B39A930-A77E-4804-8D9F-6864E1EAEDB1 wds:Q37835695-8C37C1C6-5B3F-43E8-8736-55CFA8E52AC3 wds:Q37835695-8C82391A-664E-401B-84EB-329F379505AF wds:Q37835695-90145AC4-F4DD-4346-998A-49D12EAD66EE wds:Q37835695-08FBFA15-E8F2-40E6-A553-5E2C7D499355 wds:Q37835695-0AB5B1BC-B41E-4446-80B7-9BB37487CB56 wds:Q37835695-0CC788B7-B3AC-4560-A836-2F914BEE6129 wds:Q37835695-015AAFA0-414F-4115-97E5-A64C0900A984 wds:Q37835695-04175681-B94A-4C0F-A513-D8B5C6DC4204 wds:Q37835695-05FB2DE5-5A75-49A5-BCA3-0EA44EDD5AF9 wds:Q37835695-06D2FAD6-A79B-46A6-8053-E5BF62C4AF73
wdt:P2860
wd:Q40181640 wd:Q33387698 wd:Q34592826 wd:Q37038414 wd:Q33390284 wd:Q33384668 wd:Q34166574 wd:Q37284081 wd:Q53250661 wd:Q37310407 wd:Q40339607 wd:Q42956254 wd:Q46068547 wd:Q42925566 wd:Q43189899 wd:Q46454262 wd:Q46936772 wd:Q44620764 wd:Q80599629 wd:Q28219355 wd:Q39962550 wd:Q46118120 wd:Q36624286 wd:Q33344746 wd:Q37248327 wd:Q34585268 wd:Q42965343 wd:Q30433139 wd:Q45205050 wd:Q43018754 wd:Q33303530 wd:Q53243787 wd:Q33383048 wd:Q43109172 wd:Q37280737 wd:Q33377526 wd:Q43648034 wd:Q35848744 wd:Q46482921 wd:Q36478461 wd:Q37262033 wd:Q37268930 wd:Q37306614 wd:Q43726973 wd:Q43188658 wd:Q43018499 wd:Q43245396 wd:Q55042799 wd:Q43115406 wd:Q43108154 wd:Q43195076 wd:Q33376181 wd:Q57904548 wd:Q34241661 wd:Q46859906
p:P2093
wds:Q37835695-E15A5A3D-DDE2-4E69-8FFC-A34261823F62 wds:Q37835695-F9BE2AB0-5141-4AFC-AB81-F460ADD64A6F wds:Q37835695-FD007BBC-2A5A-46ED-9779-DECF1CAD4558 wds:Q37835695-751262D1-5C66-43F6-8123-D8FE99903FC0 wds:Q37835695-806D4B85-AA10-47AF-8FAD-D45982D77EA8 wds:Q37835695-95433412-97DA-4FC5-8E9D-764B992B40D0 wds:Q37835695-CC81BB4E-293C-4620-A064-5ED23550E020 wds:Q37835695-1BC4E1F0-7421-4272-AFA6-A94D9BA09277 wds:Q37835695-15E54F73-64D0-47AC-83EC-A0B858995781 wds:Q37835695-1E02999B-A334-485C-AFE0-35F1C452F6DA wds:Q37835695-40EA84B6-AE16-4349-B6C1-739B3384D95E wds:Q37835695-65DF0AEC-DB25-434D-9184-38F90DBF359F wds:Q37835695-0ADD547A-2110-4928-976E-37DADA9E3148
wdt:P2093
P Sonneveld G J Morgan H Einsele A Palumbo M Beksaç J F San-Miguel F Leal da Costa H Ludwig U-H Mellqvist F E Davies M Delforge M Attal J-L Harousseau
rdfs:label
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
skos:prefLabel
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
schema:name
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
p:P50
wds:Q37835695-A2DD763E-6D84-4307-ADB1-404B4E216D1A wds:Q37835695-CA199869-97DB-4838-A681-196A37144F25 wds:Q37835695-D241D963-DE93-43E7-BE01-5000640C3C20 wds:Q37835695-AC95C9EF-C488-487E-A589-BE22CFD63148
wdt:P50
wd:Q92858507 wd:Q114411834 wd:Q26338766 wd:Q63639209
p:P1476
wds:Q37835695-E16A84A7-3DAA-48A7-B350-B40181C49903
wdt:P1476
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
p:P304
wds:Q37835695-B79AC7F9-E6B9-48F5-8B60-467E2B20FFC6
wdt:P304
749-760
p:P31
wds:Q37835695-32FA33A0-91CC-4CEE-96F0-81B01456B6B2
wdt:P31
wd:Q13442814
p:P921
wds:Q37835695-2DBAFC11-04F9-4C03-BC42-15280C332BBC
wdt:P921
wd:Q467635
p:P698
wds:Q37835695-15CB6DD6-0DD9-4DBA-AEAC-FE8F3ED228CF
wdtn:P698
n8:21293488
wdt:P698
21293488
p:P1433
wds:Q37835695-46F15251-7F56-4B1B-90AC-0223219B0B71
wdt:P1433
wd:Q6534498
p:P433
wds:Q37835695-832D5B1F-EB0A-4B1F-A712-80E23CB17D72
p:P478
wds:Q37835695-41FD8A16-7693-4A0A-AFBF-054A97B92EAD
wdt:P433
5
wdt:P478
25
p:P356
wds:Q37835695-46F57EAF-D39A-4B58-B1E6-602EA238AB9E
wdtn:P356
n13:LEU.2011.3
wdt:P356
10.1038/LEU.2011.3
p:P8608
wds:Q37835695-B7E4C623-977B-460D-842C-7DF4F16A79F1
wdt:P8608
release_t4va6ykixzahjlg56bxihc3jem
p:P5875
wds:Q37835695-30E0E4CA-F5CC-4634-AD57-33B27A1CF7A5
wdt:P5875
49809874
p:P6179
wds:Q37835695-D3444264-6C14-4AF5-9305-E855776C0A7C
wdt:P6179
1042228360